Investigation of the Bcl-2 multimerisation process: Structural and functional implications  by Camperchioli, Alessia et al.
Biochimica et Biophysica Acta 1813 (2011) 850–857
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrInvestigation of the Bcl-2 multimerisation process: Structural and
functional implications
Alessia Camperchioli a,1, Marisa Mariani a,1, Silvia Bartollino a,1, Lella Petrella a,1, Marco Persico b,2,
Nausicaa Orteca b,2, Giovanni Scambia a,3, Shohreh Shahabi c,3,
Cristiano Ferlini a,b,c,4, Caterina Fattorusso b,⁎,5,6
a Laboratory of Molecular Oncology, University of the Sacred Hearth, Largo A. Gemelli 1, 86100 Campobasso, Italy
b Laboratory of Computational Chemistry, Department of Natural Products Chemistry, Faculty of Pharmacy, University of Naples “Federico II,” Via D. Montesano 49, 80131 Napoli, Italy
c Danbury Hospital Research Institute, 131 West Street, Danbury, CT 06810, USA⁎ Corresponding author. Tel.: +39 081678544; fax: +
E-mail address: cfattoru@unina.it (C. Fattorusso).
1 Were responsible for performing all the experime
work, including preparation of the constructs and recom
2 Were responsible to perform calculations required fo
3 Were involved in the experimental design and
experimental results.
4 Directed the study for the in vitro section and
manuscript.
5 Directed the molecular modeling study and edi
manuscript.
6 These authors contributed equally to this work.
0167-4889/$ – see front matter © 2011 Elsevier B.V. A
doi:10.1016/j.bbamcr.2011.02.006a b s t r a c ta r t i c l e i n f oArticle history:
Received 18 October 2010
Received in revised form 15 January 2011
Accepted 7 February 2011




ApoptosisBcl-2 plays a prominent role in regulating the function of mitochondria during respiration and in determining
the threshold of apoptotic sensitivity. Despite its relevance, the mechanism through which these processes
are achieved is still unknown. Using surface plasmon resonance technology to monitor Bcl-2 multimerisation
we discovered that a simple dimeric model does not ﬁt with experimental data. A molecular model of the
experimentally observed Bcl-2 homomeric complex has been developed. Accordingly, using a panel of
mutants we identiﬁed in the loop a critical region for the process of Bcl-2 multimerisation. Our results indicate
that the Bcl-2 loop posttranscriptional changes can modulate its ability to make homo and hetero-complexes,
ultimately leading to functional modulation, suggesting an intriguing relationship between the ability of Bcl-2
to form multimeric complexes and its multi-functional role as a membrane channel.39 081678552.
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Apoptosis functions physiologically to eliminate cells without
activating inﬂammatory processes. Through the apoptotic pathway,
normal tissue homeostasis is achieved, including the removal of
damaged and infected cells. Disruption of the normal apoptotic
process underlies several diseases, most notably cancer, where the
imbalance between cell growth and apoptotic rate is responsible for
tumor development and metastasis. Chemotherapeutics and physical
treatments attempt to reactivate the apoptotic process in cancer cells,
with the goal of complete surgical resection of the tumor and
metastases or, if surgery is not sufﬁcient, to eradicate the whole
disease.Due to its status as a fundamental homeostatic process in the life
cycle of cells, apoptosis is a highly regulated pathway, with a
complex network of functions governing control and activation. In
this context, the Bcl-2 family occupies a central role, with over 25
Bcl-2 family members identiﬁed in mammalian cells to date [1,2].
Sequence homology analysis within the family allowed identiﬁcation
of 4 domains (Bcl-2 homology, BH1–4) [1]. The traditional
classiﬁcation of the Bcl-2 family divides the members into pro-
apoptotic and anti-apoptotic proteins. All the pro-apoptotic members
possess the BH3 domain and lack the BH4 domain. Some members
such as Bad, Bid, and Bim possess only the BH3 domain, which for
this reason is deﬁned as the death domain [3]. In contrast the most
important anti-apoptotic proteins (Bcl-2, Bcl-XL, Bcl-w, Mcl-1, and
A1) possess 4 BH domains. However, this Manichaean divide
between death inducers and protectors against death seems false.
In point of fact, anti-apoptotic members still possess the BH3
domain, and in some cases they are still able to induce cell death
[4–9]. Questions remain about whether the role of these proteins is
conﬁned to the regulation of apoptosis or whether they perform
other, as yet not fully recognized functions. Some possible candidates
for these are suggested by the example of mitochondria, which have
long been established as the major site of ATP production through
the processes of electron transport and oxidative phosphorylation.
The extrusion of protons from mitochondria results in modulation of
the chemical environment, including variations in pH and generation
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correlated with the intensity of the electron transport effect that is in
turn regulated by the availability of ADP as a substrate for F1F0-
ATPase. In short, when cells need energy (ATP), ADP increases and
mitochondrial production of energy is stimulated. During this
process, electron transport also generates reactive oxygen species
and oxidative stress. In this context, members of the Bcl-2 protein
family play a pivotal role in the sensitization of mitochondrial
membranes to ROS [10] and in the production of ROS itself [11], as
well as in the regulation of mitochondrial permeability to ATP [12]
and, consequently, to Δψm. These latter effects in particular could
depend on the fact that Bcl-2 proteins are structurally related to
bacterial colicins [13] and are able to form pores in cell membranes.
The channel properties of the Bcl-2 protein family members could
regulate the entry of K+, Ca++, as well as entry of the critical ADP/
ATP, thereby constituting the key regulators not only of apoptosis but
also of the mitochondrial function. Paradoxically, Bcl-2 plays an
inhibitory function when bound to the voltage-dependent anion
channel (VDAC), a macromolecular complex that crosses mitochon-
drial membranes and is known to play a critical role in the apoptotic
process. These intricate functions require interactions with other
proteins in the same family as well as posttranscriptional regulators
capable of modulating such interactions. Despite its important
physiological role, structural studies of Bcl-2 have been hampered
by the unavailability of a technology capable of monitoring the
formation of such complexes. In this present study we have tried to
characterize these processes at the molecular level using surface
plasmon resonance technology and we have attempted to produce
molecular models of the resulting complexes. Our results indicate
that the Bcl-2 loop plays a pivotal role, and that posttranscriptional
changes at these level can modulate the ability to make homo and
hetero-complexes, ultimately leading to functional modulation.2. Materials and methods
2.1. Preparation of puriﬁed proteins
Human full-length Bcl-2 was obtained from lymphocytes by PCR
with PFU Taq-polymerase (Promega) and cloned into pUSE (Upstate
Biotechnology). A construct (pUSE-Bcl2Δ) was made in which 49 aa
(32–80) were deleted by inverse PCR and replaced with a linker of 4
alanines. The PCR product was then isolated after the BamH1 and
EcoRI digestion and subsequently cloned into pQE1 (Qiagen). pQE1-
Bcl2 wild type was used as a template to replace serine 70 with
alanine (Bcl-2S70A) and glutamic acid (Bcl-2S70E). The mutations
were introduced by site directed, ligase-independent mutagenesis
(SLIM) in a multiplex PCR reaction. Two tailed primers (forward and
reverse) and two no-tailed primers (forward and reverse) to each Bcl-
2 mutation were used for each reaction. Puriﬁed proteins were freshly
puriﬁed using AKTA system (GE Healthcare) and Histraps columns
(GE Healthcare). Purity was over than 95% and a representative
Coomassie gel staining is shown in Fig. S1. Protein preparations were
never frozen and after dialysis they were kept not longer than 7 days
at 4 °C in PBS pH7.2. Cross-linking was performed with puriﬁed Bcl-2
WT recombinant protein (0.37 μg/μl). Sulfosuccinimidyl[perﬂuoroa-
zidobenzamide]ethyl1,3,dithiopropionate (SFAD, Pierce) (20.5 μg)
was used, equal to 3.5 μl of SFAD 10 mM (6 mg/ml) in DMSO. The
reaction, in a total volume of 500 μl, was incubated at room
temperature for 1 h and subsequently the solution was dialyzed vs.
PBS 1× at 4 °C overnight.
The protein conjugated with Sulfo-SFAD was mixed with a
solution of the same protein to a double concentration (0.37 μg/μl)
and was photoactivated with a UV light source. The samples of
conjugated protein and not conjugated protein (control) were run on
SDS-polyacrylamide gel.2.2. Monodimensional and two-dimensional non-reducing/reducing
SDS-polyacrylamide gels
Proteins (2 μg) were electrophoresed in reducing and non-
reducing conditions in SDS-polyacrylamide gel (12% of acrylamide).
For non-reducing condition protein samples were mixed in non-
reducing SDS-PAGE (0.25 mM Tris–HCl pH 6.8, 2% (w/v) SDS, 20%
(v/v) glycerol, 0.004% (w/v) bromophenol blue) without β-mercap-
toethanol and directly loaded into gel.
The reduced and non-reduced protein samples were loaded into
the same SDS polyacrylamide gel. Western blot was used to detect the
proteins.
A monoclonal antibody anti-polyhistidine, alkaline phosphatase
conjugate was used for the immunoblotting (Sigma). The blot was
developed using an alkaline phosphatase substrate (BCIP/NBT,
Sigma).
For two-dimensional non-reduced/reduced SDS-polyacrylamide
gel, proteins were mixed in non-reducing SDS-PAGE sample buffer
(0.25 mM Tris–HCl pH 6.8, 2% (w/v) SDS, 20% (v/v) glycerol, 0.004%
(w/v) bromophenol blue) and separated by SDS-PAGE on a 10%
acrylamide gel. Gel lanes were excised and incubated in buffer
containing 50 mM DTT for 10 min and further 10 min in 100 mM IAA
before separation through a second SDS-PAGE gel (10%).
2.3. Interaction analysis using surface plasmon resonance
(SPR) technology
Interaction analyses were performed using a Biacore T100 (GE
Healthcare). Sensor chips, N-ethyl-N′-hydroxysuccinimide (NHS),
N-ethyl-N′-(3-dimethylaminopropyl) carbodiimmide (EDC) and eth-
anolamine HC were from GE. Before starting the experiments, 10×
PBS stock solution (1×=137 mM NaCl, 10 mM phosphate, 2.7 mM
KCl, pH 7.4) was prepared. Surface of ﬂow cell 4 was activated for
7 min using a mixture of 0.1 M NHS and 0.4 M EDC. For immobili-
zation, the sensor chip was equilibrated with PBS, and then activated
by injecting 0.2 M NHS/EDC followed by 5–10 μg injection of
appropriate ligand in 10 mM Acetate at the correct pH, according
to the scouting procedure (pH 5.0 and 4.0 for Bcl-2 and Bcl-2Δ,
respectively). After immobilization, 30 μl of regeneration buffer (4 M
guanidine HCl pH 4.0) was injected to remove non covalently bound
proteins. An initial series of buffer blanks was injected ﬁrst to
equilibrate fully the system. Finally, analyte was injected from lowest
to highest concentrations using two blank injections and one
concentration in duplicate. Used analyte concentrations are here
following and each individual sensogram was independently
recorded (range 0.25–3.5 μM). All analyses were performed at
37 °C, and for studying protein–protein interactions, kinetic data
were obtained by diluting the samples in the running buffer PBS
supplemented with P20 (0.05%). The surface was regenerated after
each injection with 10 μl/min of regeneration buffer.
2.4. Structural analysis of Bcl-2 molecular model
The quality of the resulting Bcl-2 trimeric complex was assessed
using PROCHECK v.3.5 [14] and HOPPscore structure evaluator [15]
(HOPPscore v1.0 Beta; http://hoppscore.lbl.gov/) softwares and by
comparing the results with those obtained for the human Bcl-2 X-ray
structure (PDB code: 1GJH). Structural comparison with i) docking
starting structure, ii) human Bcl-2 X-ray structure, and iii) Bcl-xL X-
ray structures was performed using the Biopolymer and Homology
modules of Insight 2005 (Accelrys, San Diego). RMS values on all Cα
were calculated.
Dihedral angles and secondary structure of Bcl-2 trimeric model
were compared to human Bcl-2 X-ray structure (PDB code: 1GJH)
using Prostat/Residue_Dihedral and Prostat/SecondaryClassify (Ho-
mology module). Bcl-2 monomers of the trimeric complex were
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Bcl-xL taking into account alpha carbons of structural conserved
regions.
The experimentally determined structures of i) the pore-forming
domain of colicin A (PDB code: 1COL); ii) KcsA channel of Streptomyces
lividans (PDB code: 3EFF); iii) NaK channel of Bacillus cereus (PDB code:
3E8F) and iv) aquaporin of Pichia pastoris (PDB code: 2W1P) were
downloaded from the Protein Data Bank (PDB; http://www.rcsb.org/
pdb/), and compared to the obtained Bcl-2 trimeric complex using the
homology module of Insight 2005 (Accelrys, San Diego).
Sequence alignments were performed using Expresso (3DCoffee)
server [16] (T-Coffee, version_7.71, http://www.tcoffee.org/).
The complete experimental description of i) modeling of Bcl-2 and
its mutants, ii) docking procedure and iii) simulated annealing
procedure is in Supplemental Data.Fig. 1. SPR analysis of the Bcl-2 interactions. Representative sensograms used for the
analysis included in Table 1. Bcl-2 was used as analyte, whereas Bcl-2 in native
conditions, Bcl-2 in denaturizing and Bcl-2Δ were the analytes for A, B and C,
respectively. Each line (sensogram) corresponds to a given concentration of the analyte
protein.3. Results
3.1. SPR analysis of Bcl-2 multimerization
Bcl-2 family proteins tend to multimerize with other proteins,
including other members of the Bcl-2 family. In order to get insights
into this process, human Bcl-2 was expressed and puriﬁed and the
kinetics of multimerization was assessed using surface plasmon
resonance technology (Table 1). A representative result is shown in
Fig. 1. The obtained sensograms did not ﬁt to a simple 1:1 interaction.
The best ﬁt to the experimental data was obtained using the
heterogeneous ligand model, meaning that a simple interaction
Bcl-2/Bcl-2 leading to a dimer does not occur and that at least two
levels of interactions are present, one occurring with high afﬁnity
with a stable binding and a KD value of 2.33±0.52 nM, and another
featuring weaker values, corresponding to a KD value of 811±76 nM
(Table 1.). To further analyze this process, Bcl-2 multimerization was
followed in reducing and non-reducing conditions. In SDS page
analysis in reducing conditions no interactions and only the free
monomer were detectable (Fig. 2a). In non-reducing conditions, along
with the monomer another major complex was detectable, migrating
at a MW approximately correspondent to a complex formed by three
Bcl-2 monomers (Fig. 2a). In order to elucidate the nature of the
complex forming at lower afﬁnity, the same experiment was repeated
in non-reducing conditions after incubation of the Bcl-2 protein with
sulpho-SFAD and UV cross-linking (Bcl-2 CL). Using this procedure,
the ﬁrst interaction occurring between Bcl-2 monomers was cova-
lently stabilized. It was only by employing this approach that a
complex correspondent to a Bcl-2 dimer was clearly detectable
(Fig. 2a). In these conditions, stabilization of the Bcl-2 dimer did not
allow the formation of the trimeric structure, which suggests that
dimer formation is an intermediate step in the generation of the moreTable 1
Main kinetics parameters obtained through SPR analysis using Bcl-2 as ligand and the
other proteins as analytes.
High afﬁnity Low afﬁnity No binding
Bcl-2 wt⁎ Yes Yes No
KD 2.33±0.52 nM 811±76 nM
Bcl-2 wt (denaturized) No No Yes
Bcl-XL⁎ Yes Yes No
KD 6±0.57 nM 2720±200 nM
Bcl-2Δ⁎⁎ No Yes No
KD 261±131 nM
Bcl-2 S70A⁎ Yes Yes No
KD 0.67±0.09 nM 830±351 nM
Bcl-2 S70E No Yes No
KD 984±267 nM
⁎ Sensograms ﬁtted with the model heterogeneous ligand.
⁎⁎ Sensograms ﬁtted with the 1:1 binding model.stable trimeric structure of Bcl-2. In order to assess the relevance of pH
variations in these interactions, the technique of 2D SDS-PAGE
reducing/non-reducing was applied. Both complexes, trimeric and
dimeric, fell below the diagonal, thereby indicating the involvement
of ionizable residues in both interactions (Fig. 2b). To assess the
relevance of the loop in generation of dimers and trimers of Bcl-2, the
same experiments were repeated with a mutant of Bcl-2 in which the
loop domain (aa 35–91) was deleted and replaced with a linker
sequence of four alanine residues (Bcl-2Δ), as described by Chang et
al. [17]. Interaction analysis was repeated using Bcl-2Δ as analyte and
either Bcl-2Δ or Bcl-2 as ligand (Fig. 1). In both cases there was no
high-afﬁnity Bcl-2 trimers formation and the obtained KD value was
715±162 nM or 261±131 nM using as analytes Bcl-2Δ and Bcl-2,
respectively (Table 1). This ﬁnding suggests that the loop region is
required for the formation of high-afﬁnity trimeric Bcl-2 complexes.
In keeping with this view, when run in SDS-PAGE in non-reducing
conditions, Bcl-2Δ was unable to generate the stable trimeric Bcl-2
Fig. 2. Immunoblot analysis of the Bcl-2 complexes. (a) Western blot showing Bcl-2
pattern in denaturating (+2BME) and not denaturating conditions (−2BME). A
trimeric band was detectable with Bcl-2 and Bcl-2 S70A. Bcl2 CL corresponds to Bcl-2
treated with sulpho-FAD and UV cross-linked. Bcl-2 S70E migrates slightly higher for
the extra negative charge. (b) Immunoblotting with anti-Bcl-2 antibody after two-
dimensional non-reduced/reduced SDS-PAGE. Proteins lacking disulﬁde bonds will
migrate on the diagonal (gray line) because of the identical mobility in both
dimensions. Proteins that contain interchain disulﬁde-linked complexes will run
below the diagonal. Arrows, twomajor Bcl-2 complexes were detectable corresponding
to dimeric and trimeric complexes, respectively.
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dimer.
Conﬂicting data are present in the literature regarding the role of
serine-phosphorylation, but the most recent results tend to support
the possibility that phosphorylation at Ser70 inactivates the anti-
apoptotic role of Bcl-2 [18]. Also, it has been proposed that the anti-
apoptotic function of Bcl-2 is enhanced in a mutant in which Ser is
replaced at position 70 with Ala. Due to this mutation, the inactivating
phosphorylation at Ser70 cannot occur. In order to correlate the
impact of this mutation with the process of multimerization, we
repeated the analysis in this S70A Bcl-2 mutant. The low afﬁnity
binding site remains unaffected, while high-afﬁnity binding was
further enhanced, yielding a KD value of 0.67±0.9 nM (Table 1). This
ﬁnding points to the fact that such a mutation does not affect the
process of Bcl-2 multimerization. In keeping with these ﬁndings, in
SDS-PAGE analysis in non-reducing conditions, the formation of the
trimeric Bcl-2 complex is easily detectable (Fig. 2a). In contrast, at the
same position themutation S70Ewas used to simulate the presence ofa phosphorylated serine. Again, this mutant served as analyte using
Bcl-2S70E itself and Bcl-2 as ligand. Using Bcl-2S70E as ligand and
analyte no interactions were detectable, thereby indicating that
Bcl-2S70E is not capable of multimerizing with itself. Using Bcl-2S70E
as analyte and Bcl-2 as ligand, only the interaction at low afﬁnity was
detectable, revealing that it was still able to form complexeswith Bcl-2
but not at high afﬁnity (Table 1). In keepingwith this hypothesis,when
run in SDS-PAGE in non-denaturizing conditions, once again no
trimeric structures were detectable in the presence of Bcl-2S70E
(Fig. 2a). These results indicate a relationship between the formation
of the high-afﬁnity Bcl-2 homo-trimeric complex and the Bcl-2 anti-
apoptotic function.
Bcl-XL exhibits a high structural homology with Bcl-2 and has in
common with Bcl-2 its 4 BH domains. The higher divergence in the
sequence is present at the level of the disordered loop. To
kinetically characterize the interaction Bcl-XL/Bcl-2, the same
analysis was performed using Bcl-2 as ligand and Bcl-XL as analyte.
Similarly to the reaction that occurred with the interaction Bcl-2/
Bcl-2, also in this \case two interactions were detectable. The
stronger one (KD 6±0.57 nM) corresponded to the formation of a
hetero-dimer of Bcl-XL/ Bcl-2 with high afﬁnity, the weaker one (KD
2720±200 nM) to the formation of Bcl-XL homo-dimers (Table 1).
When comparing the results, it is evident that: i) the Bcl-XL homo-
dimer represents a low afﬁnity complex with respect to the Bcl-XL/
Bcl-2 hetero-dimer and ii) a threefold decrease in afﬁnity is present
in the interactions Bcl-XL/Bcl-2 with respect to Bcl-2/Bcl-2.
3.2. Molecular modeling of Bcl-2 homomeric complexes
Molecular models were produced to investigate the ability of Bcl-2
to assume the structure of a homo-trimeric complex, a suggestion
which emerged from experimental results. With the aim of exploring
this possibility, since all Bcl-2 experimentally determined structures
lack the amphipathic loop (aa35-91) and the C-terminal trans-
membrane region (aa208-239), our previously developed homology
model of human Bcl-2 [19] was integrated through the insertion of the
C-terminal helix. The resulting structure was then subjected to
ﬂexible docking studies in a complexwith other 2 identicalmonomers
(see Materials and methods). The entire structure was included in
docking calculations, and distance constraints were applied only to
the hydrogen bonds present in those alpha helices that turned out to
be highly conserved in secondary structure prediction calculations
(http://www.predictprotein.org/) [20], while the rest of the protein
was left free of constraints on its movement. Because the docking
protocol included a Monte Carlo-based conformational search for
“ligand” Bcl-2 in a complex with the 2 other Bcl-2 monomers, the
docking procedure was repeated 3 times, each time using a different
Bcl-2monomer as ligand. It is noteworthy that all results converged in
the same Bcl-2 homo-trimeric complex structure (Fig. 3) and that,
within this trimeric complex, all monomers were structured identi-
cally (RMS value on all Cα atoms=0.38 Å; Fig. 4). These results,
togetherwithwhatwas observed in biological assays, indicate a strong
tendency for the Bcl-2 loop to form a structure upon interactionwith 2
other Bcl-2 loops, thus forming a homo-trimeric complex. The quality
of the model was assessed using Procheck (http://www.ebi.ac.uk/
thornton-srv/software/PROCHECK/) [14] andHopp (http://hoppscore.
lbl.gov/) [15] and by comparing the results with those obtained for
human Bcl-2 X-ray structure (PDB code: 1GJH; Ramachandran plots,
Chi1-Chi2 plots, main chain parameters, side chain parameters, and
Hopp scores are reported in the Supplemental Data section).
The structure of the docked trimer presents charged loop residues
facing the same side of the complex (Fig. 3c and d) and is stabilized by
key intra- and intermolecular interactions involving the loop, such as,
hydrophobic proline–proline contacts (P39–P40; P44–P46; P57–P59;
P59–P71; P71–P75; P88–P90; P90–P91; P53–P78) (Fig. 5a). Further-
more, the loop is structured in several turns, which are stabilized
Fig. 3. Overall view of Bcl-2 homo-trimeric complex structure resulting from docking calculations. (a and c) Longitudinal view. (b and d) Transverse view. (a and b) Monomers
displayed as ribbons and colored cyan, orange, and green. (c and d) Van derWaals volumes colored by amino acid net charge [neutral: white; negative: red (Asp, Glu); positive: blue
(Lys, Arg)]. See also Ramachandran plots, Chi1–Chi2 plots, Main Chain parameters, Side Chain parameters of i) human Bcl-2 X-ray structure (PDB code: 1GJH) and ii) Bcl-2 trimer in
Supplemental Data.
Fig. 4. Superimposition of docked complex monomers taking into account all Cα
carbons. Monomers are colored cyan, orange, and green. The 2 P-pore like structures,
E13-G33 and Q118-F138, are shown with a thick, green-colored ribbon. See also Fig. S1
and Tables S1 and S2.
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A61, S87–V89; Table S2B) or by key hydrogen bonds between amino
acid side chains (H55–H58, D64–S70; Fig. 5b and c; Table S2B). Each
monomer loop projects an arginine residue (R68) towards the
“center” of the complex (Fig. 3d), towards a threonine residue (T56)
present on the loop of a partner monomer (Fig. 5c). In contrast, within
the same monomer 2 charged loop residues (R63 and D64) face 2
charged residues on α6-helix (E179 and R183; Fig. 5d).
A simulated annealing (SA) procedure was carried out to test the
stability of the docked trimer. The docking/SA protocol was also
applied to mutants Bcl-2Δ, Bcl-2S70E, and Bcl-2S70A; in addition, in
order to simulate reducing conditions used in biological studies, all
calculations were repeated at pH values of 5.3 and of 4.0. Consistent
with our experimental results, only wild-type Bcl-2 and the S70A
mutant (in non-reducing conditions) preserved the homo-trimeric
structure at the end of the computational protocol. Indeed, according
to our molecular model, i) the replacement of the loop sequence with
four Ala residues, ii) the mutation of S70 into a negatively charged
glutamate residue (mimicking S70 phosphorylation), as well as iii)
the protonation of H55 and H58 residues (occurring at pH 5.3) and iv)
aspartate D64 (occurring at pH 4), disrupted key interactions, which,
as mentioned above (Fig. 5b and c), stabilized the structure of the
complex. Thus our molecular modeling results were in agreement
with our experimentally derived data and provide a structural model
for the high-afﬁnity Bcl-2 trimeric complex experimentally observed.
Due to the dynamic conditions that existed in docking studies, the
resulting structure of Bcl-2 monomers in the trimeric complex turned
out to be different from the starting one (RMS value on all Cα
Fig. 5. Overview of major intra- and intermolecular interactions involving the docked trimer loops. Monomers are colored cyan, orange, and green. Amino acids are displayed as van
der Waals volumes (a and d) and as sticks (b and c) and colored according to atom type (white for H, blue for N, red for O). Hydrogens are omitted for the sake of clarity, with the
exception of those involved in hydrogen bond interactions. Hydrogen bonds are highlighted by green dashed lines. (a) Hydrophobic proline–proline contacts. (b) Intramolecular
hydrogen bonds between D64 and S70, as well as H55 and H58. (c) Intermolecular interaction between R68 and T56. (d) R63 and D64 (loop region) facing E179 and R183 (α6-helix).
855A. Camperchioli et al. / Biochimica et Biophysica Acta 1813 (2011) 850–857atoms=5.9 Å). The conformational changes obtained were analyzed
and compared to the X-ray structure of human Bcl-2, as well as to
experimentally determined structures of Bcl-XL (Fig. S1). No
structural data were available for the Bcl-2 α8 helix and for its long
loop, replaced by the Bcl-XL loop in the X-ray structure of human Bcl-2
(1GJH). Major secondary structural changes involved the BH4 domain
(D10-F38) and the α3/α4 region (D111-R127) (Table S2). Indeed, our
model showed the structural transition of α3 from a 310-helix (A113-
Q118) to a α-turn followed by an uncoiled strand (D111-T122). As a
consequence, the region Q118-F138 assumed a P-pore-like structure,
i.e., a strand (Q118-T122) and a helix (R127-F138) linked by a hairpin
turn to form an antiparallel structure [21]. P-pore regions are
characteristic of channels, porins and transporters; accordingly, a
structural comparison (Fig. 6) disclosed the similarity between the
consensus sequence TxxTxG present in the P-pore of the super-family
of voltage-dependent K+ channels [22] and Bcl-2 motif
122TPFTARG128. In addition, theN-terminal region L23-G33 underwent
a similar conformational change since: i) L23-R26 β-turn resolved
itself into aα-turn (L23-G27) and ii) the following segment (Y28-G33)
structure resolved into an uncoiled strand. As a result, another P-pore-
like structure (helix(E13-K22)-turn(L23-G27)-strand(Y28-G33)) was formed
at the opposite side of the protein (Fig. 4). Interestingly, the two
putative P-pore regions are inversely oriented; in particular, Q118-
F138 reproduced the aquaporins’ orientation while E13-G33 repro-
duced the voltage-dependent Na+/K+ channels’ orientation [23].
These results suggest an intriguing relationship between the ability
of Bcl-2 to form structures in homo- and hetero-multimeric
complexes and its multi-functional, multifaceted role as a membrane
channel.4. Discussion
Bcl-2 plays a prominent role in regulating the function of
mitochondria during respiration, aswell as in determining the threshold
of apoptotic sensitivity. These functions involve processes of multi-
merization aswell as interactionswithpartner proteinsbelonging to the
family or outside it. The Bcl-2 system is often viewed as a binary one in
which Bcl-2 can interactwith itself orwith other partners, which in turn
can enhance or diminish the anti-apoptotic effect. But is this
characterization of Bcl-2 as a binary system correct? Some reports
support the process of Bcl-2 homodimerization [24,25] while for other
studies this is impossible [26] However, this last study was obtained
using murine Bcl-2 and functionality of the protein was not checked
after removal of the GST-tag. Noteworthy, the investigation of protein
interactions in native conditions is difﬁcult and also in our study we
noticed that frozen proteins and preparations older than 1 week are not
suitable for functional proteomic analysis, since correct folding of the
protein is required to make possible protein–protein interactions.
Therefore, these differences can explain different outcomes reported in
literature. In this investigation we used SPR technology to directly
monitor such interactions. Using this approachwediscovered that a Bcl-
2 1:1 simple model does not ﬁt with the experimental output of a Bcl-2
multimerization. The high-afﬁnity complex is generated only when 3
molecules of Bcl-2 interact and was absent in reducing conditions. The
low afﬁnity dimeric complex is likely an intermediate in the process of
Bcl-2 multimerization and is stabilized only upon UV-dependent
chemical cross-linking. On the basis of these results, molecular models
were produced in order to investigate the ability of Bcl-2 to form a
trimeric complex. Themodelswe obtained revealed a strong propensity
Fig. 6. Comparison between the P-pore region of voltage-dependent Na/K and Bcl-2 docked monomer. Left: P-pore region of the voltage-dependent Na/K channel (PDB Code: 3E8F).
Right: Q118-F138 P-pore-like structure of Bcl-2 docked monomer. Conserved amino acids in the consensus sequence TxxTxG of the Na/K channel and in the Bcl-2 motif
122TPFTARG128 are evidenced.
856 A. Camperchioli et al. / Biochimica et Biophysica Acta 1813 (2011) 850–857of the Bcl-2 loop to form a trimeric structure upon interaction with 2
other Bcl-2 loops, identifying key intra- and intermolecular interactions
for the stabilization of the complex. A major advantage of the SPR
technology is that several conditions could be investigated simulta-
neously. Employing this advantage, using selectedmutationwe gleaned
additional insights of the key regions that, according to the model, are
involved in the process ofmultimerization. In the Bcl-2mutant inwhom
the entire loop was removed, the protein is unable to form a stable
trimeric complex. Since this mutant is functionally unable to protect
itself from cell death, this suggests that the formation of the stable
trimeric complex through the N-terminal loop is related to the anti-
apoptotic function of Bcl-2. In support of this hypothesis, the proteolytic
cleavage of the Bcl-2 loop by caspase-3 converts it from an anti-
apoptotic to a pro-apoptotic protein [4].Moreover, themutant S70A still
forms the stable trimeric complex, while the opposite effect is obtained
with the mutation S70E. This mutation mimics Serine 70 phosphory-
lation and was associated with the inhibition of multimer formation.
According to our molecular model, the formation of a charge-assisted
hydrogen bond between the side chains of S70 and D64 strongly
contributes to the stabilization of the trimeric complex (Fig. 5b and c).
The replacement of the S70 side chain with a negatively charged group,
as occurs in phosphorylation and in the S70E mutant, produces, in
contrast, a strong electrostatic repulsion to the D64 side chain, causing
the disruption of the entire complex. In fact, Bcl-2S70E cannot bind to
itself and interacts with Bcl-2 only by forming dimers at low afﬁnity.
Supporting this view, our ﬁndings are in line with the literature which
reports that thismutation abrogates the anti-apoptotic functionof Bcl-2.
On the other hand, in reducing conditions only the Bcl-2 monomer is
observed. Although the disruption of putative trimer intermolecular
disulﬁde bridges cannot be ruled out, only one cysteine (C229 on the C-
terminal helix) per monomer is accessible for disulﬁde bridge
formation, since C158 is buried inside the protein. Moreover, our
molecular simulation indicated that in reducing conditions the
protonation of loop residues, such as H55, H58, and D64, prevents the
formation of key hydrogen bond interactions which stabilized the
structure of the trimer, thus avoiding its formation. The crucial roleplayed by the loop in trimer structure and the relation between trimer
formation andBcl-2 anti-apoptotic function, are also consistentwith the
pro-apoptotic effect induced by non Bcl-2 proteins and smallmolecules,
such as Nur77 and paclitaxel [9,19]. Indeed, the binding of Nur77 and
paclitaxel to Bcl-2 loop is not compatible with its structure in the
molecularmodel of the trimer,where it is engaged inkey intermolecular
interactions; by consequence the binding of paclitaxel and Nur77 to
Bcl-2 appears to be alternative of trimer formation.
Concerning interactions with other members of the Bcl-2 family,
we investigated the ability of Bcl-XL to form complexes with Bcl-2. The
interaction of Bcl-2 and Bcl-XL led to the formation of a hetero-dimeric
complex. This means that multifamily complexes can also be
generated. However, Bcl-XL/Bcl-2 complex showed a threefold
decreased KD value as compared to the homo-dimeric Bcl-2 complex.
Bcl-2 homo- andhetero-multimerization is also related to its ability
to form different channel-like structures. Elegant electrophysiological
studies have demonstrated that the current conducted by the ion
channels formed by Bcl-2 can be explained by taking into account at
least two type of channels, one at low conductance and another with
higher conductance [27].The ion channel forming properties of Bcl-2
have been associated with its structural homology to colicins and
diphtheria toxin and are likely to play a role in regulating the
permeability of mitochondria, particularly the entry of Ca++ as also
observed in endoplasmatic reticulum [28]. A conformational change is
observed in the X-ray structure of the Bcl-XL dimer, suggesting that an
ion channel involving helices α5 and α6 can be formed if more
monomers interact [29]. Consistent with the ion channel-forming
properties of Bcl-2, conformational changes observed in our Bcl-2
trimeric model include the formation of two P-pore-like structures.
The two putative P-pore structures are inversely oriented and are
placed at opposite faces of the protein, backed against helices α5 and
α6 (Fig. 4). One is located at the N-terminal, just before the loop, and
involves the α1 helix (BH4 domain); the other is found in the α3/α4
region and shares the consensus sequence of the selectivity ﬁlter for
the super-family of voltage-gated K+ channels (Fig. 6). This latter is
part of an hydrophobic groove on the surface of the protein which
857A. Camperchioli et al. / Biochimica et Biophysica Acta 1813 (2011) 850–857represents the interaction site for the pro-apoptotic member of the
Bcl-2 family, such as Bak and Bad [30] and several experimental
molecular structures of Bcl-XL in complex with BH3 peptides are
actually available [31]. In the molecular model of the trimer this
hydrophobic groove is still accessible for the putative binding of a
partner protein; nevertheless, the P-pore like structure should
undergo a conformational change in order to allow the interaction
with a BH3 peptide.
In summary, our results support the notion that the Bcl-2 anti-
apoptotic function is associated with its ability to integrate itself into
the structure of a high-afﬁnity tri-molecular complex through the
long N-terminal loop which can modulate the formation of ion
channels. If such ion channels play a prominent role in the function of
Bcl-2, then the current prevailing view of Bcl-2 as a simple dimeric
model seems incomplete.
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